Project Number 5U01AG052460-02 Agency/Funding Organization NIA Funding Year 2017 View Full Project Details for DEVELOPMENT OF EP2 RECEPTOR ANTAGONISTS FOR SUPPRESSION OF ALZHEIMER'S NEUROPATHOLOGY Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) f. Inflammation Researcher and Organization Principal Investigator Ganesh, Thota Principal Investigator First Name Thota Principal Investigator Last Name Ganesh Awardee Organization EMORY UNIVERSITY Awardee State Georgia Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-15-174: Alzheimer's Drug-Development Program (U01) FY Overall Cost $741,585 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA